OpenLegislation

Regulation 43B Transitional provision: enforcementF1

(1)

NHS England may commence or continue any investigation of an integrated care board—

(a)

in respect of a complaint under regulation 13(1) of the National Health Service (Procurement, Patient Choice and Competition) (No. 2) Regulations 2013,

(b)

where the grounds for the complaint occurred before 1st January 2024, and

(c)

which has not been concluded before 1st January 2024,

as though it were an investigation commenced on or after that date under section 6F of the 2006 Act (and accordingly section 6F of, and Schedule 1ZA to, the 2006 Act apply to that investigation as appropriate).

(2)

In paragraph (1), an investigation of an integrated care board includes any investigation of a clinical commissioning group (as established in accordance with Chapter A2 of Part 2 of the 2006 Act as it applied before 1st July 2022)—

(a)

commenced before 1st July 2022, and

(b)

continued as against an integrated care board pursuant to regulation 21(4) of the Health and Care Act 2022 (Commencement No. 2 and Transitional and Saving Provision) Regulations 2022.

Annotations

Textual amendments

F1

Regs. 43A, 43B inserted (1.1.2024) by The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) (No. 2) Regulations 2023 (S.I. 2023/1105), regs. 1(b), 2(6)